Millie
your market intelligence analyst
Search Results
30,983,643 results
Your search in now limited to previous versions of an article. Return to results list
Elle devra s’armer de patience. Alors qu’elle a comparu pour une énième fois, hier, mardi 22 octobre, en cour intermédiaire, afin que le procès qui lui est intenté soit pris sur le fond, elle a dû rebrousser chemin. Raison : le magistrat qui préside l’audience, Raj Seebaluck, a dû fixer une nouvelle date pour la comparution de Naseera Bibi Vavra. Il était pris comme returning officer pour le Nomination Day. Naseera Bibi Vavra, connue comme la reine de Plaine-Verte, devra revenir en cour le 5 février 2020 pour l’audition des témoins. Ce n’est pas la...
Makassar Terkini (Indonesia) 10/23/2019 10:51
Terkini.id, Makassar – Penjabat Wali Kota Makassar M Iqbal Samad Suhaeb kembali mengingatkan warga Makassar untuk waspada terhadap potensi terjadinya kebakaran. Hal itu ia sampaikan saat mengunjungi lokasi kebakaran di Jalan Rajawali 1, lorong 13, Kelurahan Lette, Kecamatan Mariso, Rabu, 23 Oktober 2019. Peristiwa kebakaran tersebut terjadi pukul 06.30 Wita dan melahap enam unit rumah […]. Posting ditampilkan lebih awal di .
Business Insider 10/23/2019 10:49
released a new song called on Wednesday. The emotional breakup song , "I gave my all and they all know it / You turned me down and now it's showing / In two months, you replaced us / Like it was easy.". Fans are convinced the song is about her split from in 2018, his now-wife, . Gomez and Bieber . Selena Gomez just dropped a new song called "Lose You to Love Me," and fans already think they've decoded it. The emotional breakup song, released at midnight on Wednesday, , "I gave my all and they all know it / You turned me down and now it's showing / In two months, you replaced us / Like it was easy.". Fans are convinced the song is about her most recent split from Justin Bieber in 2018 — which reportedly went down , Hailey Bieber (née Baldwin).
GlobeNewswire 10/23/2019 10:48
WATERTOWN, Mass., Oct. 23, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies based on its immune tolerance platform technology, ImmTOR™, today presented new preclinical data from its gene therapy program at the European Society of Gene and Cell Therapy (ESGCT) Annual Congress from October 22-25, 2019 in Barcelona, Spain.

Energy

Business Issues

Companies - Public

Companies - Venture Funded

Chemicals - Agricultural

Chemicals - Industrial

Commodity Prices

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications